ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1360	National Cancer Institute	Html	en	Depression (PDQ®)–Health Professional Version	Expert-reviewed information summary about the diagnosis, assessment, and treatment of depression in adults and children who have cancer.	suicide risk 0.460973 atypical depression 0.41847 subsyndromal depression 0.457817 depressive symptoms 0.584368 suicidal cancer patients 0.447773 depression symptomatology. 0.419123 subclinical depression 0.442864 adult cancer patients 0.517419 major depression 0.691882 adolescent cancer patients 0.429802 risk factors 0.484688 sexual dysfunction 0.434954 patients 0.713623 cancer patients 0.698109 suicidal ideation 0.513185 cancer diagnosis 0.413017 major depressive episode 0.43272 reactive depression 0.424412 anxiety 0.444105 effects 0.535659 refractory depression 0.443531 certain cancer types 0.406666 minor depression 0.440711 hot flashes 0.408417 noradrenergic effects 0.403735	Cancer Patients section 0.442778 treatment 0.464007 study 0.404546 clinical depression 0.428638 general population 0.440244 palliative care 0.4121 significant depression symptomatology 0.449959 Depression Scale–defined depression 0.582176 higher suicide risk 0.426624 adjustment disorder 0.407394 definitive cancer treatment 0.418565 cancer patients. 0.417656 Depression Rating Scale. 0.455048 breast cancer 0.43696 ill cancer patients 0.449049 visual analog scale 0.432777 depressed cancer patients 0.434755 cancer-related depression 0.43502 neck cancer 0.415737 physical symptoms 0.402781 Mental Disorders 0.404693 cancer 0.740348 risk 0.54097 depression 0.900167	CLICK HERE
1544	National Cancer Institute	Html	en	Adult Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.	adult aml 0.716289 red blood cells 0.594071 cancer treatment 0.467513 blood -forming cells 0.4491 acute myeloblastic leukemia 0.44585 acute myelogenous leukemia 0.445245 chemotherapy 0.473847 PDQ cancer information 0.503817 white blood cells 0.675945 clinical trials 0.938073 mature blood cells 0.50039 cancer information summary 0.459101 clinical trial 0.615294 stem cells 0.519631 stem cell transplant 0.480735 acute granulocytic leukemia 0.446114 Myeloid Leukemia Treatment 0.448761 blood cells 0.735668 radiation therapy 0.468603 treatment 0.673705 myeloid stem cell 0.438755 stored stem cells 0.437216 immature blood cells 0.448693 arsenic trioxide 0.473356	cancer cells 0.602593 specific cancer cells 0.456728 recurrent adult aml 0.474546 untreated adult aml 0.465491 acute myeloid leukemia 0.930922 stem cell 0.533281 treatment clinical trials 0.44329 blood stem cells 0.488116 National Cancer Institute 0.460343 spinal cord 0.512703 normal cells 0.467456 myeloid stem cells 0.482174 new treatment 0.480473 white blood cell 0.463646 combination chemotherapy 0.472241 bone marrow 0.747056 cells 0.827248 acute promyelocytic leukemia 0.5928 cancer clinical trials 0.452604 acute nonlymphocytic leukemia 0.445812 acute lymphoblastic leukemia 0.434651 acute leukemia 0.43925 cancer 0.808047 standard treatment 0.467846	CLICK HERE
1647	National Cancer Institute	Html	en	Cancer Prevention Overview (PDQ®)–Patient Version	General information about cancer prevention and descriptions of the concepts used in cancer-specific prevention summaries.	cancer treatment 0.389185 cancer prevention trials 0.468498 cause cervical cancer 0.426832 cancer deaths 0.393998 cancer risk factors 0.474952 following PDQ summaries 0.808586 PDQ cancer information 0.606013 lung cancer 0.390908 cancer cell 0.406069 PDQ Cancer Clinical 0.490906 clinical trials 0.533549 female colorectal cancer 0.421435 cancer information summary 0.495456 risk factors 0.581677 breast cancer prevention 0.458936 colorectal cancer 0.45031 postmenopausal breast cancer 0.416658 lower risk 0.405329 cancer patients 0.386754 cancer risk factor 0.461133 NCI’s PDQ 0.406851 NCI PDQ cancer 0.48445 endometrial cancer 0.390827 PDQ Screening 0.394502	Cancer prevention 0.585935 cancer protective factor 0.422508 thyroid cancer 0.393113 slightly lower risk 0.392487 Cancer Information Service 0.42609 PDQ Cancer Prevention 0.489242 Prevention Editorial Board 0.417286 National Cancer Institute 0.497792 studies 0.410588 PDQ documents 0.395881 cancer share 0.415971 Cancer Prevention Trial 0.424401 modifiable risk factors 0.414325 Cancer Care page 0.410934 PDQ database 0.399212 breast cancer 0.502143 following types 0.420925 PDQ summary 0.45002 prostate cancer 0.399534 cancer clinical trials 0.466733 cancer information summaries 0.43798 comprehensive cancer information 0.431575 cancer 0.932793 risk 0.651792	CLICK HERE
1788	National Cancer Institute	Html	es	Sofocos y sudores nocturnos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los sofocos y sudores nocturnosen los pacientes de cáncer.	Visuals Online 0.455251 sudor ayuda 0.533401 Physician Data Query 0.790217 cardo lechero 0.494962 siguientes medidas 0.498906 sección síntomas vasomotores 0.544529 hierba sonajero 0.494475 terapeuta ayuda 0.487201	estudios piloto 0.477833 PDQ Sofocos 0.908716 National Cancer Institute 0.497344 siguientes riesgos 0.46265 escasa información 0.45999 frecuencia respiratoria 0.494154 Instituto Nacional 0.581027	CLICK HERE
1795	National Cancer Institute	Html	es	Delirium (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se describen enfoques de los cuidados médicos de apoyo y los abordajes farmacológicos para el manejo del delirium.	suficiente agua 0.391829 siguientes ajustes 0.389418 siguientes procedimientos 0.397737 cuánto medicamento 0.399542 problemas renales 0.399254 siguientes aspectos 0.450474 examen físico ayuda 0.42207 Physician Data Query 0.564236 sistema nervioso central 0.485961	PDQ Delirium 0.632187 múltiples alteraciones 0.425648 término delirium 0.901451 delirium ayuda 0.774253 equipo médico tomarán 0.402369 siguientes síntomas 0.497019 National Cancer Institute 0.363151 siguientes riesgos 0.350297 Instituto Nacional 0.421085	CLICK HERE
1872	National Cancer Institute	Html	es	Tratamiento del cáncer de células de transición de pelvis renal y de uréter (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de células de transición de pelvis renal y de uréter.	Compton CC 0.310067 prognostic factors 0.311079 Roth BJ 0.353197 transitional cell carcinoma 0.558604 Sin embargo 0.332107 Ta Carcinoma 0.313126 Elson PJ 0.309122 California Oncology Group 0.314515 7th ed 0.310032 tumores renales 0.309511 pelvis renal 0.960657 Instituto Nacional 0.312591 metástasis distantes 0.32208 células transicionales recidivantes 0.361913 pared pélvica renal 0.316324 parénquima renal t3 0.317938 cooperative group study 0.316918 Cooperative Oncology Group 0.315511 tejido renal 0.313083 metastatic transitional cell 0.319135 preliminary report from 0.31524 group study 0.325781 Einhorn LH 0.327583 urinary tract 0.331593 función renal 0.325386	Northern California Oncology 0.31495 upper urinary tract 0.318654 effective chemotherapy regimen 0.317306 Oncology Group study 0.317114 Nocks BN 0.30983 Cancer Staging Manual 0.321607 PDQ Tratamiento 0.309071 Renal pelvic tumors 0.315825 New York 0.30907 Daly JJ 0.308968 with paclitaxel 0.310585 Clin Oncol 0.437926 parénquima renal 0.327814 Byrd DR 0.309554 urothelial carcinoma 0.398878 gallium combination chemotherapy 0.316792 insuficiencia renal 0.313531 Eastern Cooperative Oncology 0.315974 renal pelvis 0.422209 Oncology Group 0.324511 Tis Carcinoma 0.313191 metastatic urothelial carcinoma 0.363244 AJCC Cancer Staging 0.322547 Edge SB 0.31008	CLICK HERE
1953	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los problemas de salud que continúan o aparecen después de terminar un tratamiento de cáncer.	válvulas cardíacas 0.300344 digestivasLos efectos tardíos 0.301994 siguientes procedimientos 0.300445 células madre 0.31868 suficiente saliva 0.300202 adultos jóvenes 0.300215 tumor tipo 0.3006 leucemia linfocítica aguda 0.300977 leucemia linfoblástica aguda 0.303718 diabetes mellitus 0.300401 rayos x 0.300187 largo plazo 0.301433 alta densidad 0.300367 debilidad súbitos 0.300398 efectos tardíos 0.995697 luz solar 0.30049 tumores benignos 0.300573	siguientes maneras 0.300324 hormonas tiroideas 0.300415 antecedentes familiares 0.302575 revestimiento protector 0.300332 hepatitis b 0.300262 siguientes factores 0.300516 radiación uv 0.300991 topoisomerasa ii 0.300497 suficiente insulina 0.300239 cuerpo elabora insulina 0.300315 Radiografía panorámica 0.300213 leucemia mieloide aguda 0.302575 mandíbulasLos problemas 0.300385 cáncer infantil meses 0.303991 biliaresLos efectos tardíos 0.30194 Mayor tiempo 0.300312 siguientes pruebas 0.300654	CLICK HERE
1986	National Cancer Institute	Html	es	Linfedema (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre la anatomía, la patofisiología, las manifestaciones clínicas, el diagnóstico y el tratamiento del linfedema relacionado con el cáncer, una afección en la que se acumula líquido linfático en los tejidos y causa inflamación..	after sentinel lymph 0.313822 Ridner SH 0.344357 group trial 0.315465 Sin embargo 0.344649 upper extremity lymphedema 0.331183 linfedema usa 0.380409 controlled trial with 0.318641 CA Cancer 0.317513 ganglios linfáticos centinelas 0.349529 arm lymphedema after 0.317881 extremity lymphedema after 0.335236 Cancer statistics 0.316994 treatment-related lymphedema 0.324253 lymphedema after breast 0.383555 ganglio centinela 0.352856 axillary sampling with 0.313496 conductos linfáticos subclavios 0.335825 Petrek JA 0.323456 Schmitz KH 0.339884 Sport Sci Rev 0.321461 controlled trial comparing 0.313482 randomized controlled 0.341872 Balancing lymphedema risk 0.334354 breast cancer-related lymphedema 0.386776 tronco linfático subclavio 0.332389	arm lymphedema 0.323652 axillary dissection with 0.315734 vena subclavia 0.3286 Care Cancer 0.334426 exercise versus deconditioning 0.326793 with axillary lymph 0.315505 ganglio linfático centinela 0.380935 with arm lymphedema 0.319809 Arch Phys Med 0.320628 discrepancia intramiembro 0.359416 Phys Med Rehabil 0.321125 breast carcinoma survivors 0.322235 lower-extremity lymphedema secondary 0.313534 with breast-cancer-related lymphedema 0.31752 Ahmed RL 0.322704 Clin Oncol 0.373772 breast cancer 0.91318 sentinel lymph 0.326667 Breast Cancer Study 0.332383 with or without 0.326647 Exerc Sport Sci 0.322466 axillary lymph 0.328084 Weight lifting 0.32136 Breast Cancer Res 0.331771	CLICK HERE
2016	National Cancer Institute	Html	es	Aspectos generales de la prevención del cáncer (PDQ®)–Versión para pacientes	Información general sobre la prevención del cáncer y descripciones de conceptos usados en sumarios específicos sobre la prevención del cáncer.	radiación ionizante causa 0.460647 científicos estudian 0.489171 Vitamina B12 0.441748 principales factores 0.444309 altos costos 0.431231 siguientes tipos 0.443767 Vitamina C 0.440272 determinadas sustancias 0.434346 bacteria helicobacter 0.42962 Vitamina B6 0.441932 Clinical Trials Registry 0.438953 vitamina d 0.4813 National Cancer Institute 0.429703 siguientes riesgos 0.428971 alto contenido 0.463103 ligera disminución 0.41989 vitamina e 0.538039 Instituto Nacional 0.447408	OmegA-3 TriaL 0.424385 antecedentes familiares 0.422212 sumario prevención 0.489845 Cancer Prevention Trial 0.437168 hepatitis b 0.427578 Physician Data Query 0.503692 células tumorales benignas 0.462584 Radiación ultravioleta 0.43604 Leucemia mielógena aguda 0.449074 Estados Unidos 0.563042 prevención revisa 0.457445 Physician´s Health Study 0.436091 cabo estudios 0.425211 PDQ Prevención 0.699792 siguientes vitaminas 0.436186 siguientes medicamentos 0.44035 Gas radón 0.426739 PDQ Aspectos 0.466808	CLICK HERE
16827	National Cancer Institute	Html	en	Structural Genomics Research	NCI's Center for Cancer Genomics uses structural cancer genomics to identify genomic alterations that contribute to cancer growth, metastasis, and recurrence.	Genome Research Institute 0.728945 certain childhood cancers 0.712528 dramatically positive responses 0.673976 cancer research community 0.755287 genomic profiles 0.642832 Cancer Treatment 0.810342 ovarian cancers 0.656249 lung cancer 0.670167 Cancer Therapy Evaluation 0.727719 active CGCI projects 0.698291 National Clinical Trials 0.691331 access TARGET data 0.715985 acute myeloid leukemia 0.673618 particular drug therapies 0.672703 CGCI data matrix 0.717543 comprehensive study 0.628252 National Cancer Institute 0.740247 Molecular Characterization Project 0.703185 potential therapeutic targets 0.68353 Genome Characterization Pipeline 0.731626 pediatric cancers 0.650887 comprehensive genomic approaches 0.718344 Exceptional Responders Initiative 0.693832 NCI’s Division 0.72848	genomic alterations 0.6735 download data 0.627727 structural genomics research 0.918362 CCG 0.743836 key genomic changes 0.728492 NCI-sponsored clinical trials 0.687692 cancer patients 0.672659 Genomic Data Commons 0.781309 NCI Community Oncology 0.716524 breast cancer 0.651548 cancer types 0.669231 Cancer Genome Atlas 0.81731 TCGA dataset 0.680049 different types 0.707662 oncogenic alterations 0.665162 renal cell carcinoma 0.68003 medicine clinical trial 0.701003 large B-cell lymphoma 0.698622 acute lymphoblastic leukemia 0.672538 Lymphoma Genome Sequencing 0.742417 cancer biology 0.685502 oncogenic process 0.62839 TCGA data 0.706048	CLICK HERE